Work

NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth

Year: 2019

Type: article

Source: European Journal of Medicinal Chemistry

DOI: 10.1016/j.ejmech.2019.111885

Authors: Tamer S. Kaoud, Aliaa M. Mohassab, Heba A. Hassan, Chunli Yan, Sabrina X. Van Ravenstein, Dalia Abdelhamid, Kevin N. Dalby, Mohamed Abdel-Aziz

Institutions: The University of Texas at Austin, Minia University, Georgia State University

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Welch Foundation, Cancer Prevention and Research Institute of Texas, Minia University, Graduate School, University of Texas, Austin

Awards: G52711424, Realizing Personalized and Precision Medicine for Melanoma: A Rapid Assay for Measuring ERK Activity

OpenAlex ID: W2987344358

FWCI: 1.863

Cites: 63

Cited by: 34

Related to: 10